Table 2.
Health and Functioning of COVID and non-COVID patients at admission
| COVID-19 Patients N=43 | Non-COVID patients a N= 247 | p-value | |
|---|---|---|---|
|
| |||
| QI Motor Score at Admission, mean (SD) | 48.2 (15.5) | 57.8 (14.3) | 0.0001 |
|
| |||
| BIMS Summary Score at Admission mean (SD) | 12.7 (4.0) | 13.4 (2.6) | 0.14 |
|
| |||
| Comorbidities at Admissionb, No. (%) | |||
| Essential (primary) hypertension | 20 (47) | 82 (33) | 0.092 |
| Severe protein-calorie malnutrition | 18 (42) | 90 (36) | 0.49 |
| Dysphagia | 17 (40) | 61 (25) | 0.043 |
| Type 2 diabetes | 15 (35) | 54 (22) | 0.06 |
| Anemia | 14 (33) | 55 (22) | 0.14 |
| Hyperlipidemia | 12 (28) | 56 (23) | 0.46 |
| Obesity | 11 (26) | 26 (11) | 0.006 |
| Obstructive sleep apnea | 10 (23) | 37 (15) | 0.17 |
| Long term use of anticoagulants | 10 (23) | 45 (18) | 0.43 |
| Anxiety disorder | 8 (19) | 58 (24) | 0.48 |
| Gastro-esophageal reflux disease | 8 (19) | 85 (34) | 0.041 |
| Insomnia | 8 (19) | 24 (10) | 0.085 |
| Tracheostomy Present | 8 (19) | 21 (9) | 0.042 |
| Gastrostomy Tube Present | 8 (19) | 10 (4) | 0.0002 |
| Personal history of nicotine | 8 (19) | 44 (18) | 0.90 |
| Dependence on supplemental oxygen | 7 (16) | 6 (2) | <0.0001 |
| History of Extracorporeal Membrane Oxygenation | 6 (14) | 36 (15) | 0.92 |
| Acute kidney failure | 6 (14.0) | 50 (20) | 0.34 |
| Major depressive disorder | 5 (12) | 40 (16) | 0.44 |
| Sacral Pressure Ulcer | 5 (12) | 13 (5) | 0.11 |
a
Non-COVID patients refer to the subset of patients admitted to the study facility during 2019 (pre-pandemic) with impairment group codes of 16, 10.9, and 3.3.
b
Subset of 20 most prevalent comorbidities or complications (ICD-10 codes) documented at admission for the inpatient rehabilitation COVID population.